Powered by

Powered by Portfolio Grader

Bio-Rad Laboratories (BIO)

236.56 1.34 (0.56%) 18:47 EST
BIO Stock Quote Delayed 15 Minutes

  • BIO Stock Chart

  • Historical BIO Prices

  
Dividend & Yield:       N/A (N/A)
P/E:       9.30
Market Cap:       5.84B
EPS:       25.43
Volume:       216,000
Day's Range:       236.32 - 240.53
52wk Range:       220.05 - 345.15
Quotes delayed at least 20 mins.
Historical Data for BIO
Month:  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
Year:  2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Range:  1 Month 3 Month 1 Year
Date Open High Low Volume Close Change %
01/16/19 238.75 240.53 236.32 204,561 236.56 -1.34   -0.56%
01/15/19 236.68 239.28 236.68 276,609 237.90 1.53   0.65%
01/14/19 238.50 239.45 236.37 259,502 236.37 -5.05   -2.09%
01/11/19 240.30 242.00 238.20 127,800 241.42 0.55   0.23%
01/10/19 235.88 242.15 235.68 216,735 240.87 3.50   1.47%
01/09/19 236.61 241.40 236.61 264,606 237.37 1.84   0.78%
01/08/19 235.00 236.91 232.48 234,372 235.53 1.86   0.80%
01/07/19 227.52 234.82 227.26 349,168 233.67 7.39   3.27%
01/04/19 224.50 228.34 224.11 446,700 226.28 1.98   0.88%
01/03/19 228.18 231.26 223.89 172,145 224.30 -3.78   -1.66%
01/02/19 229.73 231.23 226.73 165,788 228.08 -4.14   -1.78%
12/31/18 231.32 233.70 227.50 165,100 232.22 2.56   1.11%
12/28/18 231.34 234.47 228.20 107,600 229.66 -0.22   -0.10%
12/27/18 224.94 229.88 222.67 149,322 229.88 2.45   1.08%
12/26/18 221.00 227.75 220.05 202,705 227.43 7.33   3.33%
12/24/18 224.54 224.54 220.10 45,100 220.10 -5.35   -2.37%
12/21/18 231.62 232.00 224.82 222,600 225.45 -5.59   -2.42%
12/20/18 233.92 236.93 228.65 133,227 231.04 -3.89   -1.66%
12/19/18 240.43 243.36 232.08 264,316 234.93 -5.02   -2.09%
12/18/18 244.40 247.19 237.04 140,620 239.95 -3.07   -1.26%
12/17/18 247.58 249.37 241.56 170,808 243.02 -4.80   -1.94%
12/14/18 248.04 249.94 246.76 191,900 247.82 -2.46   -0.98%
12/13/18 255.30 255.52 246.82 198,528 250.28 -3.97   -1.56%
12/12/18 256.11 259.62 253.76 189,027 254.25 2.19   0.87%
12/11/18 254.81 256.43 250.55 243,768 252.06 0.36   0.14%
12/10/18 255.98 255.98 250.19 243,439 251.70 -4.53   -1.77%
12/07/18 262.96 264.13 255.66 263,100 256.23 -6.75   -2.57%
12/06/18 262.52 264.05 259.45 237,467 262.98 -3.42   -1.28%
12/04/18 277.85 277.85 265.72 213,900 266.40 -11.05   -3.98%
12/03/18 277.34 278.85 273.27 146,930 277.45 2.99   1.09%
11/30/18 274.12 275.91 272.67 157,000 274.46 -0.86   -0.31%
11/29/18 273.54 278.42 273.54 271,714 275.32 0.57   0.21%
11/28/18 270.66 276.25 268.29 263,391 274.75 4.77   1.77%
11/27/18 270.54 273.10 269.04 189,459 269.98 -2.61   -0.96%
11/26/18 274.85 275.17 269.32 272,784 272.59 -0.45   -0.16%
11/23/18 267.72 275.25 267.72 74,900 273.04 3.88   1.44%
11/21/18 0.00 269.16 269.16 0 269.16 4.38   1.65%
11/20/18 265.44 270.05 261.99 253,212 264.78 -3.61   -1.35%
11/19/18 274.92 274.92 268.01 274,531 268.39 -7.78   -2.82%
11/16/18 271.31 279.06 270.58 130,300 276.17 2.95   1.08%
11/15/18 267.26 274.07 264.47 149,009 273.22 4.94   1.84%
11/14/18 271.01 271.53 267.71 289,469 268.28 -0.55   -0.20%
11/13/18 272.32 276.14 267.66 174,930 268.83 -1.05   -0.39%
11/12/18 275.82 278.45 269.01 204,643 269.88 -6.54   -2.37%
11/09/18 281.29 281.29 276.01 333,500 276.42 -6.78   -2.39%
11/08/18 282.16 285.46 281.95 137,298 283.20 0.03   0.01%
11/07/18 279.63 283.80 278.01 197,894 283.17 4.29   1.54%
11/06/18 275.10 282.73 275.10 198,388 278.88 2.64   0.96%
11/05/18 269.80 279.39 269.80 285,874 276.24 6.47   2.40%
Download Data To Spreadsheet
Bio-Rad Laboratories (BIO) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Bio-Rad Laboratories Stock Analysis

Rating: Buy

Total Grade: B

Analysis Breakdown

BIO Stock Grade: B
Fundamental Grade: B
Quantitative Grade: B
BIO Earnings
Earnings Growth: A
Earnings Momentum: F
Earnings Surprises: A
Analyst Earnings Revisions: F
BIO Financial Information
Sales Growth: D
Operating Margin Growth: A
Cash Flow: B
Return on Equity: A

Bio-Rad Laboratories Stock: Weekly View

This Week: B
Last Week: B
Two Weeks Ago: B
Get Full Report